Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Pemetrexed
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Supplementation=== Patients are recommended to take [[folic acid]] and [[vitamin B12|vitamin B<sub>12</sub>]] supplement even if levels are normal when they are on pemetrexed therapy.<ref>{{cite journal | vauthors = Hazarika M, White RM, Johnson JR, Pazdur R | title = FDA drug approval summaries: pemetrexed (Alimta) | journal = The Oncologist | volume = 9 | issue = 5 | pages = 482β488 | year = 2004 | pmid = 15477632 | doi = 10.1634/theoncologist.9-5-482 | s2cid = 11444611 }}</ref><ref name="Alimta FDA label">{{cite web | title=Alimta- pemetrexed disodium injection, powder, lyophilized, for solution | website=DailyMed | date=25 March 2020 | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08 | access-date=20 October 2020 | archive-date=20 October 2020 | archive-url=https://web.archive.org/web/20201020074626/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08 | url-status=live }}</ref> (In clinical trials for mesothelioma, folic acid and B12 supplementation reduced the frequency of adverse events.) It is also recommended for patients to be on a [[glucocorticoid]] (e.g. [[dexamethasone]]) on the day prior, day of, and day after pemetrexed infusion to avoid skin rashes.<ref name="Alimta FDA label" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)